Jaguar Health (JAGX) Cash from Investing Activities (2015 - 2025)
Jaguar Health's (JAGX) quarterly Cash from Investing Activities came in at $13000.0 in Q4 2025, up 106.05% year-on-year from $6309.3 in Q4 2024, and up 106.05% on a QoQ basis from -$215000.0 in Q4 2024.
Jaguar Health (JAGX) Cash from Investing Activities (2015 - 2025) Analysis & Trends
Jaguar Health (JAGX) has 9 years of Cash from Investing Activities data on file, last reported at $13000.0 in Q4 2025.
- On a quarterly basis, Cash from Investing Activities rose 106.05% year-over-year to $13000.0 in Q4 2025; TTM through Dec 2025 was -$202000.0, a 6.05% increase from a year earlier, with the FY2025 full-year figure at -$41000.0, up 82.25% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at $13000.0, up from -$215000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for JAGX reached as high as $10.5 million in Q4 2021 and fell as low as -$10.5 million in Q3 2021.
- Historically, Cash from Investing Activities has averaged -$103166.7 across 4 years, with a median of -$135500.0 in 2022.
- Across the five-year window, Cash from Investing Activities tumbled 103.45% in 2022 and surged 106.05% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at $10.5 million in 2021, then tumbled by 103.45% to -$361000.0 in 2022, then surged by 40.44% to -$215000.0 in 2024, then jumped by 106.05% to $13000.0 in 2025.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $13000.0 in Q4 2025, -$215000.0 in Q4 2024, and -$361000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | -45.51 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | -431.90 Mn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -428.90 Mn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | -25.54 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | 172.62 Mn |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2024 | -215,000.00 |
| Dec 31, 2024 | -215,000.00 |
| Dec 31, 2022 | -361,000.00 |
| Dec 31, 2022 | -361,000.00 |
| Sep 30, 2022 | -56,000.00 |
| Sep 30, 2022 | -56,000.00 |
| Dec 31, 2021 | 10.48 Mn |
| Dec 31, 2021 | 10.48 Mn |
| Sep 30, 2021 | -10.48 Mn |
| Sep 30, 2021 | -10.48 Mn |
| Mar 31, 2020 | -7,000.00 |
| Mar 31, 2020 | -7,000.00 |
| Mar 31, 2018 | -6,527.00 |
| Mar 31, 2018 | -6,527.00 |
| Dec 31, 2017 | -11,293.00 |
| Dec 31, 2017 | -11,293.00 |
| Sep 30, 2017 | -2.06 Mn |
| Sep 30, 2017 | -2.06 Mn |